Travere Therapeutics
TVTX
TVTX
59 hedge funds and large institutions have $186M invested in Travere Therapeutics in 2014 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 27 increasing their positions, 7 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
+9
Holders Change %
+18%
% of All Funds
1.7%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
21
Increased
27
Reduced
7
Closed
12
Calls
$2.67M
Puts
$625K
Net Calls
+$2.04M
Net Calls Change
+$2.04M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$14.5M |
| 2 |
LCM
LionEye Capital Management
New York
|
+$3.56M |
| 3 |
PA
Perceptive Advisors
New York
|
+$2.7M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.11M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$1.86M |
Top Sellers
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$5.55M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$4.19M |
| 3 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$2.78M |
| 4 |
Jane Street
New York
|
-$2.53M |
| 5 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
-$1.8M |
